Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
With TRIP declaring paltry gross revenues and with over 350 million shares it has become obvious that Todd needs to leave before the ship sinks. New low recently was 11 cents. Soon it will be 10 then 9 cents or worse come summer.
Halucenex speeding up phase 2 trial
new license opens a lot of opportunities!
https://kalkinemedia.com/au/sponsored/cresos-halucenex-to-accelerate-phase-2-ptsd-trial-as-it-obtains-dealers-license-from-health-canada
Halucenex is progressing well and getting it done.
Hope the link works. An article from Cannabis Investor.
https://www.thecannabisinvestor.ca/creso-pharmas-halucenex-continues-to-make-strong-progress-in-psychedelics-industry-ahead-of-phase-ii-clinical-trials/?mc_cid=689e24373c&mc_eid=565faabdbe
Red Light Holland Signs Definitive Agreement with Mera Life Sciences and Files Annual Financial Statements:
https://stockhouse.com/news/press-releases/2021/07/30/red-light-holland-signs-definitive-agreement-with-mera-life-sciences-and-files
$TRIP $TRUFF Red Light Holland Announces Updated Cash Position of Approximately $30 Million:
https://stockhouse.com/news/press-releases/2021/07/23/red-light-holland-announces-updated-cash-position-of-approximately-30-million
$TRIP $TRUFF Red Light Holland: Bruce Linton Confirms Intention to Chair The HighBrid Lab Board of Directors:
https://stockhouse.com/news/press-releases/2021/07/19/red-light-holland-bruce-linton-confirms-intention-to-chair-the-highbrid-lab
Red Light Holland Expected Merger Partner Creso Pharma Completes Acquisition of Halucenex Life Sciences Inc:
https://stockhouse.com/news/press-releases/2021/07/15/red-light-holland-expected-merger-partner-creso-pharma-completes-acquisition-of
$TRIP $TRUFF Red Light Holland Sells Approximately 350,000 Grams of Magic Truffles and Increases Points of Sale for iMicrodose Packs to Six More Smart Shops:
https://stockhouse.com/news/press-releases/2021/07/13/red-light-holland-sells-approximately-350-000-grams-of-magic-truffles-and
Just picked up 53000
I am super heavy MNMD, but taking some of this in for the recreational side.
dont know why quiet here as other boards busy. i am all in on truff !
Thinking about taking a position here. Why so quiet?
$TRIP Red Light Holland CEO Todd Shapiro Speaks on Bruce Linton and The HighBrid Lab:
https://thedalesreport.com/psychedelics/red-light-holland-ceo-todd-shapiro-speaks-on-bruce-linton-and-the-highbrid-lab/
#SPILOCYBIN #BUYTHEDIP
Red Light Holland to Partner with Leading Fresh and Dried Mushroom Producers on East Coast Facility:
https://stockhouse.com/news/press-releases/2021/06/22/red-light-holland-to-partner-with-leading-fresh-and-dried-mushroom-producers-on
#PSILOCYBIN #BUY
$TRIP Red Light Holland Closes up 2 cents or 7.9% to close at 34 cents on volume of 3.35 million. Have a look at the following video with Bruce Linton (Founder of $WEED) discussing the $TRIP merger with $COPHF:
https://thedalesreport.com/amp/cannabis/bruce-linton-speaks-out-about-creso-red-light-holland-and-the-highbrid-lab/?__twitter_impression=true
$TRIP Red Light Holland Corp shorts fall by over 50% going from 1.87 million to 858,000. News of it's merger with Creso Pharma has gotten shorts running for the hills:
https://themarketherald.ca/creso-pharma-and-red-light-holland-merge-to-introduce-the-highbrid-lab-tm-a-leading-global-psychedelics-x-cannabis-company-specializing-in-recreational-products-applied-science-technology-and-in-2021-06-16/?utm_source=stockhouse.com&utm_medium=widget&utm_campaign=stockhouse.com%7Cwebpart_news%7Cnews_tab
#PSILOCYBIN #BUY
Today $TRIP Red Light Holland lost 4.5 cents or 12.7% as the markets were in the red. The S&P 500 dropped 55 points, Nasdaq dropped 130 points & the TSX dropped 144 points. Investors took the opportunity to buy plenty of shares as the volume was 5.76 million incl ATS.
$TRIP $CPH Red Light Holland Corp & Creso Pharma Announce Merger:
https://stockhouse.com/news/press-releases/2021/06/16/creso-pharma-and-red-light-holland-merge-to-introduce-the-highbrid-lab-tm-a
#MMJ #PSILOCYBIN
Pharmadrug Completes Strategic Mutual Investment with Red Light Holland Corp.
https://money.tmx.com/en/quote/BUZZ:CNX/news/6232590938629960/Pharmadrug_Inc_Completes_Strategic_Mutual_Investment_with_Red_Light_Holland_Corp
Toronto, Ontario--(Newsfile Corp. - July 16, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that it has completed the share exchange transasction with Red Light Holland Corp. ("RLH") (CSE: TRIP) (FSE: 4YX), an Ontario-based corporation positioning itself to engage in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, announced in the Company's July 16, 2020 press release.
Under the terms of the agreement, the Company issued 9,333,333 units to RLH (the "PharmaDrug Units") at a price of $0.075 per PharmaDrug Unit, and RLH issue 4,242,424 units (the "RLH Units") to the Company. Each PharmaDrug Unit consists of (i) one common share of PharmaDrug, (ii) 0.9 of a PharmaDrug common share purchase warrant, with each whole warrant entitling the holder thereof to acquire one common share of the Company at a price of $0.13 until July 16, 2024, and (iii) 0.1 of a PharmaDrug common share purchase warrant, with each whole warrant entitling the holder thereof to acquire one common share of PharmaDrug at a price of $0.08 until July 16, 2024. In addition, RLH subscribed for $200,000 of units of the Company, at a price of $0.075 per unit, with each unit consisting of (i) one common share of PharmaDrug, and (ii) one PharmaDrug common share purchase warrant, with each warrant entitling the holder thereof to acquire one common share of PharmaDrug at a price of $0.08 until July 16, 2024.
Each RLH Unit consists of one common share in the capital of RLH (a "RLH Share") and one RLH Share purchase warrant (a "RLH Warrant"). Each RLH Warrant entitles the holder to purchase one additional RLH Share at an exercise price of $0.26 at any time until July 16, 2024, subject to an accelerated expiry option. If, following the date that is four months and one day following the date hereof, the volume weighted average trading price of the RLH Shares on the Canadian Securities Exchange (the "CSE") for any 10 consecutive trading days equals or exceeds $0.50, RLH may, upon providing written notice to the holders of RLH Warrants, accelerate the expiry date of the RLH Warrants to the date that is 30 days following the date of such written notice.
The Company intends to use the proceeds of the $200,000 investment for working capital and general corporate purposes.
All securities of the Company issued pursuant to the above transaction are subject to a four-month hold period under applicable securities laws expiring four months and one day after the closing.
About PharmaDrug Inc.
PharmaDrug Inc. is building an international controlled substance and natural medicine company with a focus on Europe. The Company owns 80% of Pharmadrug GmbH, a German medical cannabis distributor, with a Schedule I European Union narcotics license allowing for the importation and distribution of medical cannabis to pharmacies in Germany and throughout the EU. The Company also owns 100% of Super Smart, an early-stage retail company focused on consolidating the fragmented Dutch smartshop market. Smartshops are retail establishments in The Netherlands that specialize in the sale of psychoactive substances including psychedelic truffles.
For further information, please contact:
Daniel Cohen, Chairman and CEO
dcohen@pharmadrug.co
(647) 202-1824
PharmaDrug's Super Smart Reaches Distribution Agreement with Red Light Holland for iMicrodose Packs and for Red Light Holland to Build out an iMicrodose Media Information Centre (iMIC) with Super Smart's Location in Tiel, The Netherlands
https://money.tmx.com/en/quote/BUZZ:CNX/news/4730089652586082/PharmaDrugs_Super_Smart_Reaches_Distribution_Agreement_with_Red_Light_Holland_for_iMicrodose_Packs_and_for_Red_Light_Holland_to_Build_out_an_iMicrodose_Media_Information_Centre_iMIC_with_Super_Smarts_Location_in_Tiel_The_Netherlands
Toronto, Ontario--(Newsfile Corp. - September 28, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC PINK: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that its wholly-owned subsidiary Interrobang Ltd. (doing business as Super Smart) ("Super Smart") has reached a distribution agreement with Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC:TRUFF) (Red Light Holland") for Red Light Holland's iMicrodose Packs ("iMicrodose Packs"). The iMicrodose Packs are expected to be available in Super Smart's first Slim Winkel store, located in Tiel, in early October 2020.
Red Light Holland has also definitively agreed to build and set up an iMicrodose Media Information Centre ("iMIC") in Super Smart's Tiel location, expected to be ready before the end of 2020.
"Super Smart's vision and iMicrodose's vision truly align." Said Todd Shapiro, CEO and Director of Red Light Holland. "Both Companies are focused on educating, informing and modernizing the psychedelic industry within the Netherlands. We are very excited to soon have another Store where our product is sold to expand our marketplace. Equally as important, we are proud to set up our first iMicrodose Media Information Centre - iMIC - where we will eventually provide Super Smart with our Virtual Reality Headset where consumers can truly learn about our iMicrodose packs and the origins of the product, as well as receive important customer feedback, as we want to give all consumer's a voice for important information gathering and responsible use feedback via our iMIC activation."
"Red Light Holland has definitely already taken initial steps to modernize the industry in the Netherlands and we are so pleased to house their responsible use product in our Tiel location, expected in early October 2020." Added Daniel Cohen, CEO and Chairman of PharmaDrug. "Together we want to elevate the industry, educate consumers and intelligently target all Adult Demographics for potential increased sales via new customers with an informational, technological and modern approach."
Super Smart's Tiel location is located in Central Netherlands and is the only smart shop within a 75 Kilometre radius. iMicrodose Packs powered by Red Light Holland are expected to be in Super Smart's Tiel store in October 2020.
About Red Light Holland Corp.
The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.
For additional information on the Company:
Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: todd@redlighttruffles.com
Website: https://redlighttruffles.com/
About PharmaDrug Inc.
PharmaDrug Inc. is building an international controlled substance and natural medicine company with a focus on Europe. The Company owns 80% of Pharmadrug GmbH, a German medical cannabis distributor, with a Schedule I European Union narcotics license allowing for the importation and distribution of medical cannabis to pharmacies in Germany and throughout the EU. The Company also owns 100% of Super Smart, an early-stage retail company focused on consolidating the fragmented Dutch smartshop market. Smartshops are retail establishments in The Netherlands that specialize in the sale of psychoactive substances including psychedelic truffles.
For further information, please contact:
Daniel Cohen, Chairman and CEO
dcohen@pharmadrug.co
(647) 202-1824
Why is the company name spelled wrong for this board? No wonder I could never find it.
Hope you guys can take a look at Red Light's sister company PharmaDrug(OTC:LMLLF CSE:BUZZ). Much of Red Light's EU mission involves PharmaDrug. I think PharmaDrug's a possible merger target for Red Light/Creso.
Creso Pharma and Red Light Holland Merge to Introduce The HighBrid Lab (TM), a Leading Global Psychedelics x Cannabis Company, Specializing in Recreational Products, Applied Science, Technology and Innovation
Red Light Holland to Host a Live Stream on the Company's Social Media Handles, Including www.youtube.com/redlightholland at 8:30 am Eastern Time on Thursday, June 17th
2021-06-16 08:08 ET - News Release
? Creso Pharma and Red Light Holland have entered into a definitive agreement to merge their businesses and create The HighBrid Lab
? The HighBrid Lab is expected to have an implied pro forma equity value of C$347 million (A$371 million) based on the closing price of the shares of Creso Pharma and Red Light Holland on June 15th, 2021
? Transaction results in a reverse takeover of Red Light Holland by Creso Pharma, with an implied premium to Red Light Holland Shareholders of 29.9% based on the 30-day VWAP of both companies as of June 15th, 2021
? Mr. Bruce Linton, leading cannabis and psychedelics entrepreneur, expected to join as Non-Executive Chairman of The HighBrid Lab's board of directors
? Combined Company is expected to have a cash balance of approximately C$45 million (A$48 million), providing considerable financial flexibility to progress its growth strategy
? The Combined Global Company will trade on the Canadian Securities Exchange ("CSE") under the ticker symbol TRIP
? The HighBrid Lab will focus on several key growth areas:
? Expanding market and brand leadership in recreational psilocybin, supported by education, telecounseling and technology as new markets open
? Applied science and innovation supporting long-term opportunities in psychedelics with both naturally occurring and pharmaceutical grade drug discovery aiming for advanced and approved product offerings through controlled lab environments via the pending acquisitions of Halucenex and Mera Life Sciences
? Scaling recreational cannabis offering in North America by focusing on increasing market share in Canada and taking advantage of the Combined Company's CSE listing to progress the introduction of products into the US, as well as leveraging industry leading expertise to execute US cannabis acquisitions in the near term (the US is the world's largest cannabis market, expected to reach US$41Bn/A$53Bn by 2025)
? Enhanced European distribution of Creso Pharma's researched and developed human and animal CBD products through SR Wholesale, Red Light Holland's wholly owned Netherlands based distribution company
? Introducing unique, innovative and eye-catching recreational product offerings under existing Red Light Holland brands with innovative applied science including combined CBD and mushroom products and ready to drink products with mushrooms, CBD and THC, while focusing on adding adjacent iMicrodose product lines with ingredients including CBD, THC and functional mushrooms, as and where permitted to do so, and promoting responsible use via education and information
? Creation of Red Light Farms, increasing exposure to growing operations; adding to the Combined Company's already impressive line-up including The Red Light Truffle Farm in the Netherlands, Happy Caps Gourmet Mushroom Farm and Mernova Medical in Nova Scotia
? Increasing vertical integration strategies from growing, harvesting, packaging, branding and distribution to potential brick and mortar stores for increased sales focused on higher margins
? Expanding e-commerce presence and online store initiatives to help boost future sales of CBD, THC, psilocybin, and functional mushroom products, where permissible
? Using biometric movement and scientific data and technology from Radix Motion to help find optimal dose and protocol for individuals, and to work with regulatory agencies towards expanding the legal, responsible use of psilocybin, THC and CBD in emerging countries focused on stricter controls
? Continuing to grow one of the world's most recognizable legal recreational psilocybin brands while crossing over into the cannabis sector with a focus on increasing creative and experiential marketing, brand development and added influencer support
? Sustainable approach with consideration for the long term social, environmental, and economic impacts
? Red Light Holland's current Chief Executive Officer, Todd Shapiro, will lead the Combined Company as CEO and Director. The Combined Company's board of directors will consist of seven members, three of which, including Mr. Shapiro, will be current directors of Red Light Holland, and three of which, will be directors or nominees of Creso Pharma. Mr. Bruce Linton is expected to be the seventh member, as non-executive Chairman
? Mr. William Lay, previously Associate Director, M&A at Canopy Growth appointed Executive Vice President and Chief Strategy Officer to assist in growth trajectory - Mr. Lay has overseen and/or supported over C$5Bn in cannabis M&A transactions
? Newly formed company can be accessed online at www.HighBrid.co
Sydney, Australia & Toronto, Ontario--(Newsfile Corp. - June 16, 2021) - Creso Pharma Limited ("Creso Pharma") (ASX: CPH) (FSE: 1X8) (OTCQB: COPHF), a producer of cannabis products designed to better the lives of people and animals, and Red Light Holland Corp. ("Red Light Holland") (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF), an Ontario-based corporation engaged in the production, growth and sale of magic truffles to the legal, recreational market within the Netherlands, are pleased to advise that they have entered into a definitive scheme implementation deed (the "Deed") to combine businesses and create The HighBrid Lab (the "Combined Company" or "The HighBrid Lab"), a leading global psychedelics and cannabinoid company.
Cannot view this image? Visit: https://orders.newsfilecorp.com/files/2017/87740_62b3517bd4034b2b_001.jpg
The HighBrid LabTM
To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/2017/87740_62b3517bd4034b2b_001.jpg
The transaction will be carried out by way of statutory schemes of arrangement under the Corporations Act 2001 (Cth), pursuant to which Red Light Holland will acquire (i) all of the issued fully paid ordinary shares of Creso Pharma (the "Scheme"), and (ii) all of the issued listed options of Creso Pharma (the "Option Scheme") in exchange for the issue of common shares of Red Light Holland ("Red Light Holland Shares") on the terms and conditions set forth in the Deed. Under the terms of the Deed, the shareholders of Creso Pharma (the "Creso Pharma Shareholders") will receive 0.395 of a Red Light Holland Share for each fully paid ordinary share of Creso Pharma (each, an "Creso Pharma Share") held immediately prior to the effective time of the Scheme. In addition, (i) holders of listed options of Creso Pharma (the "Creso Pharma Listed Optionholders") will receive 0.257 of a Red Light Holland Share for each listed option of Creso Pharma (each, a "Creso Pharma Listed Option") and (ii) holders of the various other classes of unlisted Creso Pharma securities will be offered Red Light Holland options or warrants based on ratios detailed in the Deed.
Upon implementation of the Scheme and the Option Scheme (together, the "Schemes"), it is expected that the former Creso Pharma securityholders will own approximately 57.4% of the pro forma issued and outstanding Red Light Holland Shares, resulting in a reverse takeover of Red Light Holland by the Creso Pharma security holders. Following implementation of the Schemes, the Combined Company is expected to have a cash balance of approximately C$45 million (A$48 million), providing considerable financial flexibility to progress its growth strategy.
About Red Light Holland
Red Light Holland strives to move towards safe and trustworthy access to psychedelic compounds for all, and is engaged in the production, growth and sale, through existing Smart Shops and an ecommerce platform, of premium magic truffles to the legal, recreational market in the Netherlands. Activities are undertaken in accordance with the highest standards and compliance with all applicable laws.
Red Light's directors and advisory board members are all highly skilled executives with extensive expertise in growing, mass-producing, compliance, distribution, marketing and supply chain management, which will allow the Combined Company to become a leader in an emerging market segment.
About Creso Pharma
Creso Pharma brings pharmaceutical expertise and methodological rigor to the cannabis world and strives for the highest quality in its products. The company develops cannabis and hemp derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. Creso Pharma uses GMP (Good Manufacturing Practice) development and manufacturing standards as a reference of quality excellence with initial product registrations in Switzerland. It has worldwide rights for several unique and proprietary innovative delivery technologies, which enhance the bioavailability, and absorption of cannabinoids. The company is also progressing expansion opportunities into the North American recreational cannabis market through its wholly-owned subsidiary Mernova Medical Inc. ("Mernova Medical"), as well as the emerging psychedelics sector through target acquisition company, Halucenex Life Sciences Inc. ("Halucenex").
Complementary Management and Board Capabilities with Industry Leading Experience
A strong management team and board of directors will lead the Combined Company, which will also have access to a world-class group of advisors. Upon completion of the Schemes, Red Light Holland's current CEO, Todd Shapiro, will lead the Combined Company as Chief Executive Officer and Director. The board of directors of the Combined Company will consist of seven members, three of which, including Mr. Shapiro, will be current directors of Red Light Holland, and three of which, will be directors or nominees of Creso Pharma. Leading cannabis entrepreneur Bruce Linton is also expected to join the board of directors of the Combined Company as non-executive Chairman.
Creso Pharma's management team brings a wealth of scientific experience and pharmaceutical background, while Red Light Holland's team has significant expertise in marketing, branding and recreational product offerings. Additionally, William Lay will lead the Combined Company's overall corporate strategy development and will work on identifying and executing potential M&A opportunities in his capacity as Executive Vice President & Chief Strategy Officer.
Creso Pharma and Red Light Holland are confident that the leadership team and proposed board of directors of the Combined Company will provide a strong foundation for The HighBrid Lab to drive shareholder value. Additional senior leadership positions at the Combined Company will be confirmed in due course.
Management Commentary
"Having worked with both the Creso Pharma and Red Light Holland teams closely in the past, I am really excited by the potential this combination brings. As a merged company, The HighBrid Lab has access to four of the highest growth industry segments around, and the team, board and advisory group to make real progress within these verticals. I'm really looking forward to rolling up my sleeves and helping The HighBrid Lab get to work!" said Bruce Linton, who is expected to join the Combined Company's board as non-executive Chairman.
"Red Light Holland has significant capital and expertise, and is motivated for growth. The company understands the sensitive complexities of the ingredients we deal with, while ensuring we continue to make a bold yet careful push to provide and increase access for immediate revenue generation and brand expansion. Our core principle is to compliantly lead with edgy consumer packaged goods focused on positive outcomes, while balancing a responsible, regulated and educational use approach through technology and innovation," said Todd Shapiro CEO and Director of Red Light Holland. "Merging with Creso Pharma, who also has significant cash on hand, and formulating The HighBrid Lab, with Bruce Linton as Chair of the Board, means we can expand our premium product offerings globally in the high growth CBD, THC and psychedelic sectors. Together we are bullish on developing world class products with naturally occurring ingredients in clever and innovative ways for both humans and pets, which completely aligns with Creso Pharma's R&D and sales approach. The HighBrid Lab ramps up our objectives for near and long term growth targets, while potentially being a part of positive change. Together we are not shy, as our goal continues to be the People's Company, dedicated to providing global access to each of these naturally occurring ingredients while understanding that education, careful use, sustainability and data collection with consent are the keys to future success as regulations open up. The HighBrid Lab is a perfect name combining psychedelics and cannabis coupled with recreational use, science and technology. This is a monumental day for all of our shareholders and now their pets!"
Creso Pharma's Non-Executive Chairman, Mr. Adam Blumenthal said: "We are very excited to have entered into this agreement with Red Light Holland and to create a company that has the potential to become a world leading psychedelic, CBD and recreational and medicinal cannabis company. The transaction follows a considerable amount of due diligence undertaken by both parties, highlighting the strength of both Creso Pharma's and Red Light Holland's operations and abilities across a number of key international markets. There are a number of synergies across the businesses, which will allow the Combined Company to considerably scale up operations in the near term. Red Light's CSE-listed vehicle will allow the Combined Company to enter the lucrative US market and we anticipate that product sales through our recreational cannabis and CBD subsidiaries will scale up significantly in the short term, underpinning early cash generation and provide additional financial flexibility across the business."
"To oversee this rapid growth phase, the The HighBrid Lab will be led by an experienced board of directors and strategic advisors, who are expected to bring a wealth of knowledge to building successful cannabis, recreational products and psychedelics companies. Creso Pharma is very confident that Red Light Holland's established operations including a distribution arm and market understanding will provide a number of value catalysts. We look forward to working with the group to immediately refine our supply chain, increase brand awareness through North America and progress opportunities across the recreational and therapeutic psychedelics sectors to unlock value for new and existing shareholders."
Today $TRIP "Red Light Holland Corp" traded 3.77 million shares at an average SP of 36.12 cents to close up 1.4% to finish at 36.5 cents. Investors seem confident that $TRIP will see 40 cents before the end of the week.
$TRIP Red Light Holland Corp had an excellent week trading well over 2 million shares a day with 3.7 million shares traded incl ATS on Friday. For the week, the SP rose 4.5 cents or 14.2% to close at 36 cents.
#PSILOCYBIN #BUY
$TRIP Red Light Holland Closes Acquisition of 80% of Happy Caps Mushroom Farm - Specializing in Grow-At-Home Mushroom Kits
https://stockhouse.com/news/press-releases/2021/06/10/red-light-holland-closes-acquisition-of-80-of-happy-caps-mushroom-farm
#PSILOCYBIN #BUY
$TRIP Red Light Holland Corp closes acquisition:
https://stockhouse.com/news/press-releases/2021/06/08/red-light-holland-closes-acquisition-of-cutting-edge-silicon-valley-applied
#PSILOCYBIN
$TRIP Red Light Holland Corp closed the day up 1 cent or 3.2% to finish on its high of 32.5 cents on 2.67 million shares. Great volume considering the daily average is 1.47 million. This one has been slowly going back up under the radar.
$TRIP Red Light Holland Corp. investors await in excitement for tomorrow market open expecting a big move on the SP as California passes a bill to legalize the possession of Psychedelics:
https://www.marijuanamoment.net/california-senate-approves-bill-to-legalize-possession-of-psychedelics-like-psilocybin-and-lsd/
$TRIP Moved up 2 cents or 6.7% to close at 32 cents on over 1.59 million shares traded incl ATS. A pretty exciting day for a slow Monday in Canada when the US markets were closed for Memorial Day.
$SPDR $CLSH $HBOR
Nice! I have dry powder :)
$TRIP Shorts are down by another 331,000 shares. A good indication that the share price will start rising again.
$SPDR $HBOR $CLSH $NUMI $MMED #MMJ #PSILOCYBIN #PROFIT #INVESTING
NEWS OUT ! https://www.newsfilecorp.com/release/83613?fbclid=IwAR2OC46ryYMPvILF1oUfihM2-BtLUmsPPrmnRiQhphrSx4bDHVnWVc1pon0
Red Light Holland iMicro Digital Care App and Telecounseling Goes Live
Toronto, Ontario--(Newsfile Corp. - May 11, 2021) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) ("Red Light Holland" or the "Company") is pleased to announce its ground-breaking iMicro app, which includes Virtual Telecounseling and uses biometric pose detection data to help people find their optimal dose, after months of beta testing, is now live on https://www.imicroapp.com/. The app was developed based on the latest behavioural science as well as interviews with Microdosing individuals to understand their pain points, for example the difficulty of sticking to a non-daily dosing regimen, the lack of a supporting community and the difficulty of finding a personal optimal dose.
"Our goal is to promote mindfulness and responsible use of microdosing. The iMicro app does that by using the most advanced pose detection technology that can give people objective insights into their body and subconsciousness and by connecting people to the best Microdosing experts in the world. The app also promotes a well-established practice of journaling and does all that while being focused on users privacy," said Sarah Hashkes CTIO or Red Light Holland. "There are too many apps out there that sell users' data and are not aligned with their users' well being. Red Light Holland strongly believes that the psychedelic ecosystem needs to be different and we are glad to lead by example with our technology in hopes that other psychedelic companies will follow."
"We are continuing our path as a trailblazing company creating unique technology and intellectual property that we believe will benefit humanity. This app along with the consensual data we get from it will help us build more infrastructure and support structures to promote the responsible use and legalization of psychedelics worldwide," said Red Light Holland CEO and Director, Todd Shapiro. "Feel free to go to www.iMicroapp.com to learn more as we push forward with our carefully thought out movement via our educational, informational and supportive approach to #FreeTheMagic."
About Red Light Holland Corp.
The Company is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.
For additional information on the Company:
Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: todd@redlighttruffles.com
Website: https://redlighttruffles.com/
Forward-Looking Statements
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties, certain of which are beyond the control of Red Light Holland. Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Forward looking statements include, but are not limited to: statements pertaining to the intended uses and expected functions of the iMicro app, data collection and privacy protection, statements regarding the Company's technology and intellectual property, and the optimism surrounding the Company's anticipated positive outcomes of the use of the Company's products in the psychedelics sector.
Forward-looking information is based on a number of key expectations and assumptions made by Red Light Holland, including without limitation: no change to laws or regulations that negatively affect Red Light Holland's business; there will be a demand for Red Light Holland's products in the future; no unanticipated expenses or costs arise; and the Company will be able to continue to develop products that are used and sold in the psychedelics industry. Although the forward-looking information contained in this news release is based upon what the Company believes to be reasonable assumptions, it cannot assure investors that actual results will be consistent with such information.
Forward-looking information is provided for the purpose of presenting information about management's current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. Forward-looking information involves significant risks and uncertainties and should not be read as a guarantee of future performance or results, as actual results may differ materially from those expressed or implied in such forward-looking information. Those risks and uncertainties include, among other things, risks related to: renewing federal, provincial, municipal, local or other licenses and any inability to obtain all necessary governmental approvals, licenses, and permits to operate and expand the Company's facilities; regulatory or political change such as changes in applicable laws and regulations, including federal and provincial legalization, due to inconsistent public opinion, perception of the medical-use and adult-use psilocybin industry, bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth; the Company's limited operating history; reliance on management; the Company's requirements for additional financing; and competition for mental health and wellness investments. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although the Company has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements.
The Company assumes no obligation to update forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
Not for distribution to United States newswire services or for dissemination in the United States.
$TRIP is back below 30 cents as the spam and touting has lost its effectiveness. The FOMO is gone... I suggest looking at more solid companies such as NUMI and MMED.
#PSILOCYBIN
Americans are not known for observing anything outside their borders. lol this works very well for me. We seldom get an opportunity to be first position. The webull, robinhood crowd can not play, any institution with federal ties can not touch it till a banking act or heaven forbid, legalization. That leaves it open to US retailers with an understanding the world consists of more than the USA, small investment companies that have no fear of the feds and... the rest of the world. This is growing quietly and steadily and by the time the walls come down multi generational wealth will be made. It suits me that they continue to drag their feet. I am making money when the shorts manipulate the price. Charting has become a handy tool. Halo is the first American business they have worked with. Their other work is done in Europe and Canada. That is why Canopy, Aphria, Tilray and a few others are at such ridiculous prices. Not because their business is good but because they are the only plant touching companies on US boards. Aleafia has more market share and products than canopy and they are under a buck. I love it! There is a big shake up coming and we have the front row seat to all these “new discoveries” that have been around for years. You will not get market info from Bloomberg. Weedmaps is a better place for DD. Usually the otc boards are reserved for start up mining operations hoping to get bought out. These last few years they have hosted real companies with real business forced here by the schizophrenic laws in the USA. Some companies are crappy, some are good. California legalized 5 years ahead of the rest of the world but they are hogtied. The progression from wild enthusiasm, to confusing rollouts then over growth tanking prices then an actual balance of supply and demand with novel products made with good weed as the final outcome with most weed sold by the bushel rather than the gram. Although there will always be a place for flower CPG products will be bigger eventually. We have a great long way to go yet. First inning batters are just warming up. So much fun to watch it unfoldz Anyone reading this has the opportunity of a lifetime at their finger tips.
Evidently they're only real in the Great White North.
In the U.S. they're as mythical as Bigfoot and honest politicians.
Why else would their board be abandoned?
Lol! Welcome to my world
Bottom line is in any currency, is that Todd & RLH are for real. Lots of potential. All shareholders will be pleased if they aren’t already.
I'm not good enough at word problems to buy on CNSX.
Liam wants to buy 150,000 shares of TRIP @ .34 per share.
A barrel of maple syrup contains 34.972317 imperial gallons and Liam can sell it for $1550.
There are 4.54609 liters in one imperial gallon.
Liam owns 282 sugar maple trees and each one produces an average of 66.4 liters of sap every 3 days.
If each liter of sap makes 29 ml of syrup after boiling, how many days will it take Liam to collect enough sap to pay for the shares?
Bonus question: What color is Liam's tuque?
I do not know, Im the one that usually gets shut out in favour of the US boards. Im okay with it in my currency on my charts :)
Why was the TRUFF board shut down?
A lot of investors only trade US stocks.
And why hasn't anyone corrected the name of the stock here yet? It's not Hollard.
$TRIP/TRUFF: His connection are amazing..........
And how they got Russell Peters on Board ????
I love it.
Dave Chappelle next :)
GO $TRUFF
Bruce knows where the opportunities are. He knows every angle of the industry
$TRUFF/TRIP: MindMED uplisting to Nasdaq is good for $TRUFF
Bigggggggggg run up happened on $MMEDF and now its listed as $MNMD
Looks like we are gonna head in that same direction.
Should be solid run for $TRUFF here with Linton and Peters doign the lifting.
GO $TRUFF
Todd & Bruce did another great interview on WSR the other day. . Very informative. We’ll get back to its highs & beyond.
Followers
|
17
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
224
|
Created
|
08/23/20
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |